SAN DIEGO, Nov. 04, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistula, LLP announces that a class action lawsuit has been filed on behalf of investors in Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ: SMFR, SMFRW). The class action is on behalf of shareholders who have since purchased Sema4 securities March 14, 2022 and August 15, 2022, both dates inclusive (the “Class Period”). Investors are hereby notified that they have until November 7, 2022 to request the court to appear as lead plaintiff in this lawsuit.

What actions can I take at this time? If you have suffered a loss and would like to learn more about being a lead plaintiff, please contact Jim Baker ([email protected]) by email or phone at 619-814-4471. When emailing, please include your phone number.

To participate in this promotion you can click on the following link or copy and paste it into a browser:

https://www.cognitoforms.com/JohnsonFistel/Sema4HoldingsCorp

There are no costs or obligations for you.

The Complaint filed in this Class Action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects. Specifically, Defendants failed to disclose to investors: (1) that there was a significant risk that Sema4 would reverse a substantial amount of previously recognized revenue that it was unable to recover from third-party payers; (2) that the company experienced decreasing selling prices for its reproductive health segment; (3) that Sema4’s financial results would be adversely affected as a result of the foregoing; and (4) that as a result of the foregoing, defendants’ positive statements about the Company’s business, operations and prospects were materially misleading and/or lacked any reasonable basis.

A lead plaintiff will act on behalf of all other group members in directing the Sema4 class action. The lead plaintiff…